FindTrial
Sign In

Clinical study to see the effect of some ayurvedic formulation in the treatment of conjunctivitis.

Single arm clinical trial to evaluate the efficacy of Bilvamuladi Kwath Aschyotana in the management of Kaphaj Abhishyanda.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/05/052658
Enrollment
50
Registered
2023-05-15
Start date
Unknown
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H108- Other conjunctivitis Health Condition 2: H109- Unspecified conjunctivitis

Interventions

None listed

Sponsors

Sane Guruji Arogya Kendra
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All patients having signs and symptoms of Kaphaj Abhishyand as 1 Netra Guruta(Heaviness in eyes ) 2 Netra Kandu(Itching in eyes) 3 Pichchil Strav(Sticky Discharge) 4 Akshi Shopha(Oedema on eyes)

Exclusion criteria

Exclusion criteria: Patients with Vataj and Pittaj Abhishyanada. Patients having systemic illnesses like DM, HTN, Bronchitis or any other severe ocular infections like corneal ulceration, retinal disease. Patients with any autoimmune disorders for e.g. Rheumatoid Arthritis Patients with Immunosuppressive disorders like HIV

Design outcomes

Primary

MeasureTime frame
Netra Guruta, Kandu, Pichchil Strav will be decreased , subject will get relief from Kaphaj Abhishyanda. Timepoint: Follow up will be taken on 3 rd and 7 th day symptoms will be noted of before and after treatment—

Secondary

MeasureTime frame
Subject will get relief from Atishopha, Atishaityam. Timepoint: 18 months—

Countries

India

Contacts

Public ContactDr Sumedha Y Kotangale

M. A. M. s Sumatibhai Shah Ayurved Mahavidyalay, Hadapsar, Pune

sumedhayk@yahoo.com8275298480

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026